Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Precancerous Conditions 4Colorectal Neoplasms 4Breast Neoplasms 4Adenomatous Polyposis Coli 4Neoplasms 3Colonic Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Unspecified Adult Solid Tumor, Protocol Specific 1Tobacco Use Disorder 1Rectal Neoplasms 1Pathologic Complete Response 1Pancreatic Intraductal Neoplasms 1Pain 1Melanoma 1Leukoplakia, Oral 1Leukemia, Myeloid, Acute 1Inflammation 1Hypertension 1Desmoid Tumors 1Coproporphyria 1Colonic Polyps 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Aberrant Crypt Foci 1

Interventions

Colonoscopy 13Polyethylene Glycols 3Surgical Instruments 2Endoscopic Mucosal Resection 2sodium phosphate 1prucalopride 1picosulfate sodium 1peppermint oil 1maltodextrin 1Sulindac 1Simethicone 1Ringer's Lactate 1Reference Standards 1Proflavine 1Optical Imaging 1Occult Blood 1Narrow Band Imaging 1MoviPrep 1Menthol 1Mass Screening 1Iohexol 1Hydroxyethyl Starch Derivatives 1Folic Acid 1Eflornithine 1Diatrizoate Meglumine 1Diagnosis, Computer-Assisted 1Defecation 1Colonography, Computed Tomographic 1Citric Acid 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Colonic Polyps × Sulindac × Clear all
NCT01245816 2015-04-24

A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)

Cancer Prevention Pharmaceuticals, Inc.

Phase 3 Withdrawn
Gastrointestinal

Colonic Polyps, Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon âš¡